NCT05704777

Brief Summary

EYE-FIT is a randomized clinical trial with a two-arm parallel design aimed at assessing the impact of performing a structured and supervised physical training program on the different variables associated with glaucoma progression in pharmacologically treated primary open angle glaucoma patients. This intervention will include a supervised 24-weeks concurrent (endurance + resistance) training program comparing its influence to the standard care.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
136

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 30, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 30, 2023

Completed
2 days until next milestone

Study Start

First participant enrolled

February 1, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

January 30, 2023

Status Verified

January 1, 2023

Enrollment Period

1.9 years

First QC Date

December 30, 2022

Last Update Submit

January 19, 2023

Conditions

Keywords

ExerciseMultidisciplinary interventionEye care

Outcome Measures

Primary Outcomes (6)

  • Change from baseline glaucomatous damage in the retina at 6 months

    Optical coherence tomography for the assessment of glaucomatous damage in the macula and optic nerve head

    Baseline (week 0) and after-intervention (week 25)

  • Change from baseline visual fields at 6 months

    Evaluation of the visual fields with the Humphrey Field Analyzer using the Swedish Interactive Thresholding Algorithm (24-2) SITA-Standard protocol .

    Baseline (week 0) and after-intervention (week 25)

  • Changes from baseline anterior eye morphology and corneal biomechanics at 6 months

    Assessment of the anterior chamber morphology using the Pentacam Scheimpflug camera and the biomechanics of the cornea using the Corvis ST.

    Baseline (week 0) and after-intervention (week 25)

  • Change from baseline electrophysiological activity in the retina at 6 months

    Examination of the functional state of the retina with the photopic negative response and pattern ERG

    Baseline (week 0) and after-intervention (week 25)

  • Change from baseline intraocular pressure at 6 months

    Assessment of intraocular pressure levels

    Baseline (week 0) and after-intervention (week 25)

  • Change from baseline ocular perfusion pressure at 6 months

    Indirect calculation of ocular perfusion pressure by the measure of intraocular pressure and blood pressure

    Baseline (week 0) and after-intervention (week 25)

Secondary Outcomes (13)

  • Self-reported vision-targeted health status

    Baseline (week 0) and after-intervention (week 25)

  • Glaucoma-specific questionnaire

    Baseline (week 0) and after-intervention (week 25)

  • Glaucoma-related quality of life

    Baseline (week 0) and after-intervention (week 25)

  • Health-related quality of life

    Baseline (week 0) and after-intervention (week 25)

  • Self-rated health in mobility, self-care, usual activities, pain/discomfort and anxiety/depression

    Baseline (week 0) and after-intervention (week 25)

  • +8 more secondary outcomes

Study Arms (2)

exercise

EXPERIMENTAL

The intervention (endurance + resistance training) group will perform 48 training sessions (24 weeks, twice per week). In each session, they will perform the leg and arm cycling exercises during the first half of the session (15 minutes of leg cycling and 15 minutes of arm cycling) and resistance training exercises involving the lower-body (e.g., squat) and upper-body (e.g., a variety exercises performed against the resistance imposed by elastic bands) during the second half of the session.

Behavioral: ExerciseOther: Control

control

NO INTERVENTION

The control group will not perform any supervised training program, and will follow standard care.

Interventions

ExerciseBEHAVIORAL

A 24-weeks concurrent exercise training program

exercise
ControlOTHER

Usual care

exercise

Eligibility Criteria

Age50 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Have an age between 50 and 70 years old
  • No have undergone any surgical intervention for glaucoma treatment
  • Be medically treated with prostaglandin analogues or with a combination of prostaglandin analogue and beta-blockers

You may not qualify if:

  • Have an scheduled surgery for the following 6 months
  • Have a sufficient level of mobility to perform supervised physical exercise
  • Suffer any disease that prevent the practice of physical exercise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Granada

Granada, Spain

Location

MeSH Terms

Conditions

Glaucoma, Open-AngleGlaucomaMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Ocular HypertensionEye DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Masking Details
The assessment of the outcomes will be performed by researchers blinded to the group allocation of each participant.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 30, 2022

First Posted

January 30, 2023

Study Start

February 1, 2023

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

January 30, 2023

Record last verified: 2023-01

Locations